Dogwood Therapeutics (DWTX) News Today $4.77 +0.04 (+0.85%) Closing price 04:00 PM EasternExtended Trading$4.78 +0.01 (+0.10%) As of 06:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock DWTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Dogwood Therapeutics Approves CFO Salary IncreaseJuly 25 at 9:10 AM | theglobeandmail.comDogwood Therapeutics raises CFO Angela Walsh’s base salary to $321,903July 4, 2025 | investing.comDogwood Therapeutics Approves Equity Plan AmendmentJune 24, 2025 | tipranks.comDWTX Dogwood Therapeutics, Inc.June 10, 2025 | seekingalpha.comDogwood Therapeutics to Present at Sidoti Small-Cap Virtual ConferenceJune 3, 2025 | finance.yahoo.comDogwood Therapeutics to Present at Sidoti Small-Cap Virtual ConferenceJune 3, 2025 | globenewswire.comDWTX: Phase 2b Trial in Chemotherapy Induced Neuropathic Pain Underway…May 14, 2025 | finance.yahoo.comDogwood Therapeutics Stock Short Interest Report | NASDAQ:DWTX | BenzingaMay 9, 2025 | benzinga.comDogwood Therapeutics Announces First Quarter 2025 Financial ResultsMay 8, 2025 | finance.yahoo.comDogwood Therapeutics Announces First Quarter 2025 Financial ResultsMay 8, 2025 | globenewswire.comHC Wainwright & Co. Upgrades Dogwood Therapeutics (DWTX)April 23, 2025 | msn.comDogwood receives Nasdaq confirmation of complianceApril 11, 2025 | markets.businessinsider.comDogwood Therapeutics, Inc. Receives Nasdaq Confirmation of ComplianceApril 11, 2025 | financialpost.comFDogwood Therapeutics, Inc. Receives Nasdaq Confirmation of ComplianceApril 11, 2025 | globenewswire.comDogwood management to meet with MaximApril 9, 2025 | markets.businessinsider.comDWTX: Interim Data for Phase 2b Trial in 4Q25…April 5, 2025 | msn.comDogwood regains Nasdaq complianceApril 4, 2025 | markets.businessinsider.comDogwood Therapeutics, Inc. Regains Nasdaq ComplianceApril 3, 2025 | globenewswire.comDogwood Therapeutics Announces Fourth Quarter and Full Year 2024 Financial ResultsMarch 31, 2025 | globenewswire.comDogwood doses first patient in Phase 2b trial of HalneuronMarch 18, 2025 | markets.businessinsider.comDWTX: First Patient Dosed in Phase 2b Trial of Halneuron in CINP; Debt Conversion Strengthens Balance Sheet…March 18, 2025 | msn.comDogwood Therapeutics Announces Dosing of First Patient in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy-Induced Neuropathic PainMarch 18, 2025 | globenewswire.comMaxim Group Remains a Buy on Dogwood Therapeutics (DWTX)March 13, 2025 | markets.businessinsider.comDogwood Therapeutics, Inc. Announces Pricing of $4.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq RulesMarch 13, 2025 | financialpost.comFDogwood Therapeutics, Inc. Announces Conversion of Existing $19.5M in Debt to Equity, Strengthening Balance Sheet Moving ForwardMarch 12, 2025 | financialpost.comFDogwood Therapeutics IncMarch 10, 2025 | cnn.comDogwood Therapeutics Becomes Most Actively Discussed Biotech Stock Among Retail Traders After Stunning 370% SurgeJanuary 25, 2025 | msn.comDogwood Therapeutics Announces Patient Dosing in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy Induced Neuropathy (CINP) to Commence First Quarter of 2025January 21, 2025 | globenewswire.com Get Dogwood Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address DWTX Media Mentions By Week DWTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DWTX News Sentiment▼1.891.06▲Average Medical News Sentiment DWTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DWTX Articles This Week▼21▲DWTX Articles Average Week Get Dogwood Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ITRM News AKTX News KPTI News SNYR News CLSD News KZR News CLNN News OKUR News RNTX News FGEN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DWTX) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dogwood Therapeutics, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Dogwood Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DWTX Stock Alerts